Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 35, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012990.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
T-cell surface glycoprotein CD3 epsilon chain-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane immune signaling adaptor TYROBP
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TYRO protein tyrosine kinase-binding protein
uncharacterized LOC122540566, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122540566, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC122540566 isoform X2
uncharacterized protein LOC122540566 isoform X1
uncharacterized LOC122540566, transcript variant X4
uncharacterized LOC122540566, transcript variant X3
uncharacterized LOC122540566, transcript variant X5
uncharacterized LOC122540566, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC122540566 isoform X3
apolipoprotein A-IV-like, transcript variant X2
apolipoprotein A-IV-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 2, transcription factor 3
rho guanine nucleotide exchange factor 12-like, transcript variant X1
rho guanine nucleotide exchange factor 12-like, transcript variant X2
rho guanine nucleotide exchange factor 12-like isoform X1
rho guanine nucleotide exchange factor 12-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
glutamate receptor, ionotropic, kainate 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor, ionotropic, kainate 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor, ionotropic, kainate 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 101 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate receptor ionotropic, kainate 4 isoform X3
glutamate receptor ionotropic, kainate 4 isoform X2
glutamate receptor ionotropic, kainate 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
glutenin, high molecular weight subunit DX5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TEN1 subunit of CST complex, transcript variant X2
TEN1 subunit of CST complex, transcript variant X1
TEN1 subunit of CST complex, transcript variant X4
TEN1 subunit of CST complex, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122540575, transcript variant X2
uncharacterized LOC122540575, transcript variant X1
uncharacterized LOC122540575, transcript variant X3
sortilin-related receptor, L(DLR class) A repeats containing, transcript variant X2
sortilin-related receptor, L(DLR class) A repeats containing, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin-associated and SH3 domain-containing protein B-like, transcript variant X1
ubiquitin-associated and SH3 domain-containing protein B-like, transcript variant X2
ubiquitin-associated and SH3 domain-containing protein B-like isoform X1
ubiquitin-associated and SH3 domain-containing protein B-like isoform X2
uncharacterized LOC122540580, transcript variant X1
uncharacterized LOC122540580, transcript variant X2
uncharacterized protein LOC122540580 isoform X1
uncharacterized protein LOC122540580 isoform X2
interleukin-18-like, transcript variant X2
interleukin-18-like, transcript variant X1
interleukin-18-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
interleukin-18-like, transcript variant X3
pleckstrin homology-like domain, family B, member 1b, transcript variant X1
pleckstrin homology-like domain, family B, member 1b, transcript variant X2
pleckstrin homology-like domain, family B, member 1b, transcript variant X10
pleckstrin homology-like domain, family B, member 1b, transcript variant X8
pleckstrin homology-like domain, family B, member 1b, transcript variant X13
pleckstrin homology-like domain, family B, member 1b, transcript variant X3
pleckstrin homology-like domain, family B, member 1b, transcript variant X4
pleckstrin homology-like domain, family B, member 1b, transcript variant X15
pleckstrin homology-like domain, family B, member 1b, transcript variant X7
pleckstrin homology-like domain, family B, member 1b, transcript variant X14
pleckstrin homology-like domain, family B, member 1b, transcript variant X16
pleckstrin homology-like domain, family B, member 1b, transcript variant X17
pleckstrin homology-like domain, family B, member 1b, transcript variant X9
pleckstrin homology-like domain, family B, member 1b, transcript variant X6
pleckstrin homology-like domain, family B, member 1b, transcript variant X18
pleckstrin homology-like domain, family B, member 1b, transcript variant X20
pleckstrin homology-like domain, family B, member 1b, transcript variant X21
pleckstrin homology-like domain family B member 1 isoform X1
pleckstrin homology-like domain family B member 1 isoform X3
pleckstrin homology-like domain family B member 1 isoform X4
pleckstrin homology-like domain family B member 1 isoform X6
pleckstrin homology-like domain family B member 1 isoform X2
pleckstrin homology-like domain family B member 1 isoform X10
pleckstrin homology-like domain family B member 1 isoform X14
pleckstrin homology-like domain family B member 1 isoform X7
pleckstrin homology-like domain family B member 1 isoform X13
pleckstrin homology-like domain family B member 1 isoform X17
pleckstrin homology-like domain family B member 1 isoform X8
pleckstrin homology-like domain family B member 1 isoform X12
pleckstrin homology-like domain family B member 1 isoform X15
pleckstrin homology-like domain family B member 1 isoform X16
pleckstrin homology-like domain family B member 1 isoform X19
pleckstrin homology-like domain family B member 1 isoform X9
pleckstrin homology-like domain family B member 1 isoform X20
pleckstrin homology-like domain, family B, member 1b, transcript variant X12
pleckstrin homology-like domain, family B, member 1b, transcript variant X5
pleckstrin homology-like domain family B member 1 isoform X5
pleckstrin homology-like domain, family B, member 1b, transcript variant X11
pleckstrin homology-like domain family B member 1 isoform X11
pleckstrin homology-like domain, family B, member 1b, transcript variant X19
pleckstrin homology-like domain family B member 1 isoform X18
NLR family member X1, transcript variant X6
NLR family member X1, transcript variant X5
NLR family member X1, transcript variant X2
NLR family member X1, transcript variant X1
NLR family member X1, transcript variant X4
NLR family member X1, transcript variant X3
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like, transcript variant X4
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like, transcript variant X1
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like, transcript variant X2
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like isoform X1
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like isoform X4
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like isoform X2
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like isoform X5
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like, transcript variant X3
Na(+)/H(+) exchange regulatory cofactor NHE-RF3-like isoform X3
ubiquitination factor E4A (UFD2 homolog, yeast), transcript variant X1
ubiquitination factor E4A (UFD2 homolog, yeast), transcript variant X2
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit g
lysine (K)-specific methyltransferase 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
lysine (K)-specific methyltransferase 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
lysine (K)-specific methyltransferase 2A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
lysine (K)-specific methyltransferase 2A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
lysine (K)-specific methyltransferase 2A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
histone-lysine N-methyltransferase 2A isoform X1
histone-lysine N-methyltransferase 2A isoform X2
histone-lysine N-methyltransferase 2A isoform X3
histone-lysine N-methyltransferase 2A isoform X4
histone-lysine N-methyltransferase 2A isoform X5
transmembrane protein 25, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 25, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 25, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
marginal zone B- and B1-cell-specific protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
interleukin-20 receptor subunit alpha-like, transcript variant X2
interleukin-20 receptor subunit alpha-like isoform X2
interleukin-20 receptor subunit alpha-like, transcript variant X1
interleukin-20 receptor subunit alpha-like isoform X1
small integral membrane protein 35-like, transcript variant X1
small integral membrane protein 35-like, transcript variant X2
uncharacterized protein LOC122540507 isoform X1
small integral membrane protein 35-like isoform X2
transmembrane protease serine 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane protease serine 4-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protease serine 4-like isoform X3
transmembrane protease serine 4-like, transcript variant X4
transmembrane protease serine 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane protease serine 4-like, transcript variant X5
transmembrane protease serine 4-like isoform X2
transmembrane protease serine 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protease serine 4-like isoform X1
transmembrane protease serine 4-like isoform X4
transmembrane protease serine 4-like isoform X5
sodium channel subunit beta-4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sodium channel subunit beta-4-like, transcript variant X2
sodium channel, voltage-gated, type II, beta, transcript variant X1
sodium channel subunit beta-2 isoform X1
sodium channel, voltage-gated, type II, beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sodium channel subunit beta-2 isoform X2
myelin protein P0-like, transcript variant X1
myelin protein P0-like, transcript variant X2
sterol-C5-desaturase, transcript variant X1
sterol-C5-desaturase, transcript variant X2
sterol-C5-desaturase, transcript variant X3
glucuronokinase with putative uridyl pyrophosphorylase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glucuronokinase with putative uridyl pyrophosphorylase isoform X2
glucuronokinase with putative uridyl pyrophosphorylase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glucuronokinase with putative uridyl pyrophosphorylase isoform X1
beta,beta-carotene 9',10'-oxygenase-like, transcript variant X1
beta,beta-carotene 9',10'-oxygenase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
beta,beta-carotene 9',10'-oxygenase-like isoform X1
beta,beta-carotene 9',10'-oxygenase-like isoform X2
beta,beta-carotene 9',10'-oxygenase-like, transcript variant X4
beta,beta-carotene 9',10'-oxygenase-like, transcript variant X3
beta,beta-carotene 9',10'-oxygenase-like isoform X4
beta,beta-carotene 9',10'-oxygenase-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger and BTB domain containing 16a, transcript variant X4
zinc finger and BTB domain containing 16a, transcript variant X3
zinc finger and BTB domain containing 16a, transcript variant X1
zinc finger and BTB domain containing 16a, transcript variant X2
zinc finger and BTB domain containing 16a, transcript variant X7
zinc finger and BTB domain containing 16a, transcript variant X6
zinc finger and BTB domain containing 16a, transcript variant X5
zinc finger and BTB domain-containing protein 16-A
5-hydroxytryptamine receptor 3A-like, transcript variant X1
5-hydroxytryptamine receptor 3A-like isoform X1
5-hydroxytryptamine receptor 3A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5-hydroxytryptamine receptor 3A-like isoform X2
5-hydroxytryptamine (serotonin) receptor 3B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5-hydroxytryptamine (serotonin) receptor 3B, transcript variant X3
5-hydroxytryptamine (serotonin) receptor 3B, transcript variant X2
5-hydroxytryptamine (serotonin) receptor 3B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
5-hydroxytryptamine receptor 3B isoform X1
5-hydroxytryptamine receptor 3B isoform X2
ubiquitin specific peptidase 28, transcript variant X2
ubiquitin specific peptidase 28, transcript variant X3
ubiquitin specific peptidase 28, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 28 isoform X1
ubiquitin carboxyl-terminal hydrolase 28 isoform X2
ubiquitin carboxyl-terminal hydrolase 28 isoform X3
ubiquitin specific peptidase 28, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 28 isoform X4
tetratricopeptide repeat domain 12, transcript variant X3
tetratricopeptide repeat protein 12 isoform X3
tetratricopeptide repeat domain 12, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
tetratricopeptide repeat domain 12, transcript variant X2
tetratricopeptide repeat protein 12 isoform X1
tetratricopeptide repeat protein 12 isoform X2
tetratricopeptide repeat domain 12, transcript variant X4
tetratricopeptide repeat protein 12 isoform X4
ankyrin repeat and kinase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ankyrin repeat and protein kinase domain-containing protein 1
transmembrane serine protease 5, transcript variant X4
transmembrane serine protease 5, transcript variant X3
transmembrane serine protease 5, transcript variant X1
transmembrane serine protease 5, transcript variant X2
dopamine receptor D2a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dopamine receptor D2a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dopamine receptor D2a, transcript variant X1
dopamine receptor D2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
centromere/kinetochore protein zw10 homolog
G protein-activated inward rectifier potassium channel 4-like, transcript variant X3
G protein-activated inward rectifier potassium channel 4-like, transcript variant X2
G protein-activated inward rectifier potassium channel 4-like, transcript variant X1
G protein-activated inward rectifier potassium channel 4-like isoform X1
G protein-activated inward rectifier potassium channel 4-like isoform X2
grass carp reovirus (GCRV)-induced gene 2o
ATP-binding cassette, sub-family G (WHITE), member 4a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ATP-binding cassette, sub-family G (WHITE), member 4a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ATP-binding cassette sub-family G member 4 isoform X1
ATP-binding cassette sub-family G member 4 isoform X2
ATP-binding cassette, sub-family G (WHITE), member 4a, transcript variant X3
ATP-binding cassette sub-family G member 4 isoform X3
ring finger protein 214, transcript variant X2
ring finger protein 214, transcript variant X1
ring finger protein 214, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122540621, transcript variant X2
uncharacterized LOC122540621, transcript variant X4
uncharacterized LOC122540621, transcript variant X1
uncharacterized LOC122540621, transcript variant X3
uncharacterized protein LOC122540621 isoform X2
uncharacterized protein LOC122540621 isoform X1
uncharacterized protein LOC122540621 isoform X4
uncharacterized protein LOC122540621 isoform X3
phospholipid transfer protein C2CD2L isoform X2
phospholipid transfer protein C2CD2L isoform X1
histone H4 transcription factor, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
histone H4 transcription factor, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histone H4 transcription factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
histone H4 transcription factor, transcript variant X3
histone H4 transcription factor, transcript variant X4
histone H4 transcription factor, transcript variant X5
histone H4 transcription factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
histone H4 transcription factor, transcript variant X6
histone H4 transcription factor isoform X1
histone H4 transcription factor isoform X2
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase)
UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 73% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC553749 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122540628, transcript variant X2
uncharacterized LOC122540628, transcript variant X1
uncharacterized protein C11orf53 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein C11orf53 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein C11orf53 homolog isoform X2
uncharacterized protein C11orf53 homolog isoform X1
uncharacterized LOC122540632, transcript variant X2
uncharacterized LOC122540632, transcript variant X3
uncharacterized LOC122540632, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SIK family kinase 3, transcript variant X3
SIK family kinase 3, transcript variant X5
SIK family kinase 3, transcript variant X2
SIK family kinase 3, transcript variant X1
SIK family kinase 3, transcript variant X6
SIK family kinase 3, transcript variant X4
serine/threonine-protein kinase SIK3 homolog isoform X2
serine/threonine-protein kinase SIK3 homolog isoform X5
serine/threonine-protein kinase SIK3 homolog isoform X4
serine/threonine-protein kinase SIK3 homolog isoform X3
serine/threonine-protein kinase SIK3 homolog isoform X1
platelet-activating factor acetylhydrolase 1b, catalytic subunit 2
platelet-activating factor acetylhydrolase IB subunit beta
SID1 transmembrane family, member 2, transcript variant X1
SID1 transmembrane family, member 2, transcript variant X3
SID1 transmembrane family, member 2, transcript variant X2
SID1 transmembrane family, member 2, transcript variant X4
SID1 transmembrane family, member 2, transcript variant X5
SID1 transmembrane family member 2 isoform X1
SID1 transmembrane family member 2 isoform X3
SID1 transmembrane family member 2 isoform X2
SID1 transmembrane family member 2 isoform X4
SID1 transmembrane family member 2 isoform X5
SID1 transmembrane family, member 2, transcript variant X6
SID1 transmembrane family member 2 isoform X6
palmitoyl-protein thioesterase ABHD10, mitochondrial-like, transcript variant X1
palmitoyl-protein thioesterase ABHD10, mitochondrial-like, transcript variant X2
palmitoyl-protein thioesterase ABHD10, mitochondrial-like
proprotein convertase subtilisin/kexin type 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
proprotein convertase subtilisin/kexin type 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
proprotein convertase subtilisin/kexin type 7
glucose-6-phosphate exchanger SLC37A4-like, transcript variant X1
glucose-6-phosphate exchanger SLC37A4-like, transcript variant X2
glucose-6-phosphate exchanger SLC37A4-like isoform X1
glucose-6-phosphate exchanger SLC37A4-like isoform X2
E3 ubiquitin-protein ligase TTC3-like, transcript variant X5
E3 ubiquitin-protein ligase TTC3-like, transcript variant X2
E3 ubiquitin-protein ligase TTC3-like, transcript variant X4
E3 ubiquitin-protein ligase TTC3-like, transcript variant X3
E3 ubiquitin-protein ligase TTC3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
E3 ubiquitin-protein ligase TTC3-like, transcript variant X6
E3 ubiquitin-protein ligase TTC3-like isoform X3
E3 ubiquitin-protein ligase TTC3-like isoform X2
E3 ubiquitin-protein ligase TTC3-like isoform X1
E3 ubiquitin-protein ligase TTC3-like isoform X4
E3 ubiquitin-protein ligase TTC3-like isoform X5
trafficking protein particle complex subunit 4
salt-inducible kinase 2a, transcript variant X1
serine/threonine-protein kinase SIK2a isoform X1
salt-inducible kinase 2a, transcript variant X2
serine/threonine-protein kinase SIK2a isoform X2
protein phosphatase 2, regulatory subunit A, beta a, transcript variant X1
protein phosphatase 2, regulatory subunit A, beta a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
protein phosphatase 2, regulatory subunit A, beta a isoform X1
protein phosphatase 2, regulatory subunit A, beta a isoform X2
ALG9 alpha-1,2-mannosyltransferase, transcript variant X6
ALG9 alpha-1,2-mannosyltransferase, transcript variant X4
ALG9 alpha-1,2-mannosyltransferase, transcript variant X1
ALG9 alpha-1,2-mannosyltransferase, transcript variant X2
ALG9 alpha-1,2-mannosyltransferase, transcript variant X3
ALG9 alpha-1,2-mannosyltransferase, transcript variant X7
ALG9 alpha-1,2-mannosyltransferase, transcript variant X5
alpha-1,2-mannosyltransferase ALG9 isoform X6
alpha-1,2-mannosyltransferase ALG9 isoform X4
alpha-1,2-mannosyltransferase ALG9 isoform X2
alpha-1,2-mannosyltransferase ALG9 isoform X1
alpha-1,2-mannosyltransferase ALG9 isoform X3
alpha-1,2-mannosyltransferase ALG9 isoform X7
alpha-1,2-mannosyltransferase ALG9 isoform X5
chromosome 35 C11orf1 homolog, transcript variant X2
chromosome 35 C11orf1 homolog, transcript variant X3
ferredoxin-fold anticodon binding domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ferredoxin-fold anticodon binding domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ferredoxin-fold anticodon binding domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X2
ferredoxin-fold anticodon-binding domain-containing protein 1 isoform X1
chromosome 35 C11orf1 homolog, transcript variant X1
heat shock protein, alpha-crystallin-related, b2, transcript variant X2
heat shock protein, alpha-crystallin-related, b2, transcript variant X1
uncharacterized protein C11orf52 homolog, transcript variant X2
uncharacterized protein C11orf52 homolog, transcript variant X1
uncharacterized protein C11orf52 homolog isoform X1
uncharacterized protein C11orf52 homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex), transcript variant X1
dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex), transcript variant X2
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial isoform X1
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial isoform X2
dihydrolipoamide S-acetyltransferase (E2 component of pyruvate dehydrogenase complex), transcript variant X3
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial isoform X3
PIH1 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
PIH1 domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PIH1 domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
NKAP domain containing 1, transcript variant X1
NKAP domain containing 1, transcript variant X5
NKAP domain containing 1, transcript variant X2
NKAP domain containing 1, transcript variant X4
NKAP domain containing 1, transcript variant X3
cell adhesion molecule 1a, transcript variant X4
cell adhesion molecule 1a, transcript variant X5
cell adhesion molecule 1a, transcript variant X2
cell adhesion molecule 1a, transcript variant X3
cell adhesion molecule 1a, transcript variant X1
cytotoxic and regulatory T-cell molecule, transcript variant X1
cytotoxic and regulatory T-cell molecule, transcript variant X3
cytotoxic and regulatory T-cell molecule, transcript variant X2
cytotoxic and regulatory T-cell molecule, transcript variant X5
cytotoxic and regulatory T-cell molecule, transcript variant X4
cytotoxic and regulatory T-cell molecule isoform X1
cytotoxic and regulatory T-cell molecule isoform X3
cytotoxic and regulatory T-cell molecule isoform X2
cytotoxic and regulatory T-cell molecule isoform X4
heat shock cognate 71 kDa protein, transcript variant X1
heat shock cognate 71 kDa protein, transcript variant X2
heat shock cognate 71 kDa protein isoform X2
heat shock cognate 71 kDa protein isoform X1
heat shock cognate 71 kDa protein-like, transcript variant X1
heat shock cognate 71 kDa protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC122540666 isoform X2
uncharacterized protein LOC122540666 isoform X1
uncharacterized protein LOC122540666 isoform X3
sorting nexin 19b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
sorting nexin 19b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
sorting nexin 19b, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 15-like
A disintegrin and metalloproteinase with thrombospondin motifs 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 8-like, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 8-like isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 8-like isoform X1
zinc finger and BTB domain-containing protein 44-like, transcript variant X3
zinc finger and BTB domain-containing protein 44-like, transcript variant X1
zinc finger and BTB domain-containing protein 44-like, transcript variant X2
zinc finger and BTB domain-containing protein 44-like, transcript variant X4
zinc finger and BTB domain-containing protein 44-like, transcript variant X5
zinc finger and BTB domain-containing protein 44-like
uncharacterized LOC122540671, transcript variant X2
uncharacterized LOC122540671, transcript variant X1
uncharacterized LOC122540672, transcript variant X1
uncharacterized LOC122540672, transcript variant X3
uncharacterized LOC122540672, transcript variant X2
neural cell adhesion molecule 1-like, transcript variant X19
neural cell adhesion molecule 1-like, transcript variant X17
neural cell adhesion molecule 1-like, transcript variant X18
neural cell adhesion molecule 1-like, transcript variant X6
neural cell adhesion molecule 1-like, transcript variant X13
neural cell adhesion molecule 1-like, transcript variant X9
neural cell adhesion molecule 1-like, transcript variant X8
neural cell adhesion molecule 1-like, transcript variant X5
neural cell adhesion molecule 1-like, transcript variant X4
neural cell adhesion molecule 1-like, transcript variant X12
neural cell adhesion molecule 1-like, transcript variant X7
neural cell adhesion molecule 1-like, transcript variant X2
neural cell adhesion molecule 1-like, transcript variant X11
neural cell adhesion molecule 1-like, transcript variant X3
neural cell adhesion molecule 1-like, transcript variant X10
neural cell adhesion molecule 1-like, transcript variant X1
neural cell adhesion molecule 1-like isoform X19
neural cell adhesion molecule 1-like isoform X17
neural cell adhesion molecule 1-like isoform X18
neural cell adhesion molecule 1-like isoform X6
neural cell adhesion molecule 1-like isoform X13
neural cell adhesion molecule 1-like isoform X9
neural cell adhesion molecule 1-like isoform X8
neural cell adhesion molecule 1-like isoform X5
neural cell adhesion molecule 1-like isoform X4
neural cell adhesion molecule 1-like isoform X12
neural cell adhesion molecule 1-like isoform X7
neural cell adhesion molecule 1-like isoform X2
neural cell adhesion molecule 1-like isoform X11
neural cell adhesion molecule 1-like isoform X3
neural cell adhesion molecule 1-like isoform X10
neural cell adhesion molecule 1-like isoform X1
neural cell adhesion molecule 1-like, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
neural cell adhesion molecule 1-like isoform X20
neural cell adhesion molecule 1-like, transcript variant X21
neural cell adhesion molecule 1-like, transcript variant X22
neural cell adhesion molecule 1-like, transcript variant X16
neural cell adhesion molecule 1-like, transcript variant X15
neural cell adhesion molecule 1-like, transcript variant X14
neural cell adhesion molecule 1-like isoform X21
neural cell adhesion molecule 1-like isoform X22
neural cell adhesion molecule 1-like isoform X16
neural cell adhesion molecule 1-like isoform X15
neural cell adhesion molecule 1-like isoform X14
uncharacterized LOC122540514, transcript variant X2
uncharacterized LOC122540514, transcript variant X1
uncharacterized LOC122540678, transcript variant X3
uncharacterized LOC122540678, transcript variant X2
uncharacterized LOC122540678, transcript variant X1
uncharacterized protein LOC122540678 isoform X2
uncharacterized protein LOC122540678 isoform X1
uncharacterized protein LOC393330 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nicotinamide N-methyltransferase-like, transcript variant X3
nicotinamide N-methyltransferase-like, transcript variant X5
nicotinamide N-methyltransferase-like, transcript variant X2
nicotinamide N-methyltransferase-like, transcript variant X1
nicotinamide N-methyltransferase-like, transcript variant X4
nicotinamide N-methyltransferase-like isoform X2
nicotinamide N-methyltransferase-like isoform X1
thymocyte nuclear protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
thymocyte nuclear protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
thymocyte nuclear protein 1, transcript variant X4
thymocyte nuclear protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
thymocyte nuclear protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
vacuolar protein sorting-associated protein 26B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
non-SMC condensin II complex, subunit D3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
non-SMC condensin II complex, subunit D3, transcript variant X2
condensin-2 complex subunit D3 isoform X1
condensin-2 complex subunit D3 isoform X2
non-SMC condensin II complex, subunit D3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
condensin-2 complex subunit D3 isoform X3
junctional adhesion molecule 3b, transcript variant X2
junctional adhesion molecule 3b, transcript variant X1
junctional adhesion molecule 3B isoform X2
junctional adhesion molecule 3B isoform X1
immunoglobulin superfamily, member 9Bb, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
immunoglobulin superfamily, member 9Bb, transcript variant X2
immunoglobulin superfamily, member 9Bb, transcript variant X3
immunoglobulin superfamily, member 9Bb, transcript variant X5
immunoglobulin superfamily, member 9Bb, transcript variant X4
immunoglobulin superfamily, member 9Bb, transcript variant X6
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mth938 domain-containing protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mth938 domain-containing protein-like, transcript variant X1
mth938 domain-containing protein-like, transcript variant X2
CXADR-like membrane protein, transcript variant X2
CXADR-like membrane protein, transcript variant X1
protein Aster-B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein Aster-B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein Aster-B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein Aster-B-like, transcript variant X2
protein Aster-B-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein Aster-B-like, transcript variant X6
protein Aster-B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein Aster-B-like, transcript variant X8
protein Aster-B-like, transcript variant X7
sodium channel, voltage-gated, type III, beta, transcript variant X4
sodium channel, voltage-gated, type III, beta, transcript variant X5
sodium channel, voltage-gated, type III, beta, transcript variant X2
sodium channel, voltage-gated, type III, beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sodium channel, voltage-gated, type III, beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
potassium-transporting ATPase alpha chain 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 215 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium-transporting ATPase alpha chain 2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium-transporting ATPase alpha chain 2-like, transcript variant X8
potassium-transporting ATPase alpha chain 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium-transporting ATPase alpha chain 2-like, transcript variant X4
potassium-transporting ATPase alpha chain 2-like, transcript variant X2
potassium-transporting ATPase alpha chain 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 236 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium-transporting ATPase alpha chain 2-like isoform X1
potassium-transporting ATPase alpha chain 2-like isoform X6
potassium-transporting ATPase alpha chain 2-like isoform X7
potassium-transporting ATPase alpha chain 2-like isoform X5
potassium-transporting ATPase alpha chain 2-like isoform X3
potassium-transporting ATPase alpha chain 2-like isoform X2
potassium-transporting ATPase alpha chain 2-like, transcript variant X5
potassium-transporting ATPase alpha chain 2-like isoform X4
uncharacterized protein CXorf65 homolog, transcript variant X2
uncharacterized protein CXorf65 homolog, transcript variant X1
uncharacterized protein CXorf65 homolog, transcript variant X3
uncharacterized protein LOC122540698 isoform X3
uncharacterized protein LOC122540698 isoform X2
uncharacterized protein CXorf65 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57% coverage of the annotated genomic feature by RNAseq alignments
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85% coverage of the annotated genomic feature by RNAseq alignments
nuclear factor of activated T-cells, cytoplasmic 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1-like, transcript variant X4
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
junctional cadherin complex regulator, transcript variant X1
junctional cadherin complex regulator, transcript variant X2
brain-specific homeobox, transcript variant X2
brain-specific homeobox, transcript variant X1
brain-specific homeobox protein homolog isoform X2
brain-specific homeobox protein homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myb/SANT-like DNA-binding domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
cystathionine beta-synthase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cystathionine beta-synthase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cystathionine beta-synthase-like, transcript variant X3
cystathionine beta-synthase-like isoform X1
cystathionine beta-synthase-like isoform X2
uncharacterized LOC122540704, transcript variant X1
uncharacterized LOC122540704, transcript variant X2
uncharacterized protein LOC122540704 isoform X2
uncharacterized protein LOC122540704 isoform X1
uncharacterized LOC122540705, transcript variant X1
uncharacterized LOC122540705, transcript variant X2
uncharacterized LOC122540711, transcript variant X3
uncharacterized LOC122540711, transcript variant X1
uncharacterized LOC122540711, transcript variant X2
opioid binding protein/cell adhesion molecule-like, transcript variant X4
opioid binding protein/cell adhesion molecule-like, transcript variant X1
opioid binding protein/cell adhesion molecule-like, transcript variant X3
opioid binding protein/cell adhesion molecule-like, transcript variant X2
opioid binding protein/cell adhesion molecule-like, transcript variant X5
opioid-binding protein/cell adhesion molecule isoform X4
opioid-binding protein/cell adhesion molecule isoform X5
opioid-binding protein/cell adhesion molecule isoform X3
opioid-binding protein/cell adhesion molecule isoform X2
opioid-binding protein/cell adhesion molecule isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 140 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
V-set and immunoglobulin domain-containing protein 2-like
endothelial cell adhesion molecule a, transcript variant X1
endothelial cell adhesion molecule a, transcript variant X3
endothelial cell adhesion molecule a, transcript variant X2
endothelial cell adhesion molecule a isoform X1
endothelial cell adhesion molecule a isoform X2
roundabout, axon guidance receptor, homolog 3 (Drosophila), transcript variant X1
roundabout, axon guidance receptor, homolog 3 (Drosophila), transcript variant X5
roundabout, axon guidance receptor, homolog 3 (Drosophila), transcript variant X2
roundabout, axon guidance receptor, homolog 3 (Drosophila), transcript variant X3
roundabout, axon guidance receptor, homolog 3 (Drosophila), transcript variant X4
roundabout, axon guidance receptor, homolog 3 (Drosophila), transcript variant X6
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
roundabout, axon guidance receptor, homolog 4 (Drosophila), transcript variant X2
roundabout, axon guidance receptor, homolog 4 (Drosophila), transcript variant X1
roundabout, axon guidance receptor, homolog 4 (Drosophila), transcript variant X3
pbx/knotted 1 homeobox 2, transcript variant X3
pbx/knotted 1 homeobox 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
pbx/knotted 1 homeobox 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pbx/knotted 1 homeobox 2, transcript variant X8
pbx/knotted 1 homeobox 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pbx/knotted 1 homeobox 2, transcript variant X5
pbx/knotted 1 homeobox 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pbx/knotted 1 homeobox 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122540524, transcript variant X2
uncharacterized LOC122540524, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
transmembrane protein 218, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transmembrane protein 218, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
phosphodiesterase 9ab, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphodiesterase 9ab, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A isoform X1
high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A isoform X2
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
coiled-coil domain containing 15, transcript variant X2
coiled-coil domain containing 15, transcript variant X1
coiled-coil domain-containing protein 15 isoform X2
coiled-coil domain-containing protein 15 isoform X1
hepatic and glial cell adhesion molecule b, transcript variant X1
hepatic and glial cell adhesion molecule b, transcript variant X2
hepatic and glial cell adhesion molecule b isoform X1
hepatic and glial cell adhesion molecule b isoform X2
hepatic and glial cell adhesion molecule b, transcript variant X3
hepatic and glial cell adhesion molecule b isoform X3
arginyl-tRNA--protein transferase 1-like, transcript variant X3
arginyl-tRNA--protein transferase 1-like, transcript variant X2
arginyl-tRNA--protein transferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
arginyl-tRNA--protein transferase 1-like isoform X2
arginyl-tRNA--protein transferase 1-like isoform X1
arginyl-tRNA--protein transferase 1-like isoform X3
fasciculation and elongation protein zeta 1 (zygin I), transcript variant X2
fasciculation and elongation protein zeta 1 (zygin I), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
fasciculation and elongation protein zeta-1 isoform X1
fasciculation and elongation protein zeta-1 isoform X2
uncharacterized LOC122540732, transcript variant X2
uncharacterized LOC122540732, transcript variant X1
uncharacterized LOC122540732, transcript variant X3
EI24 autophagy associated transmembrane protein
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X2
STT3 oligosaccharyltransferase complex catalytic subunit A, transcript variant X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A
checkpoint kinase 1, transcript variant X3
checkpoint kinase 1, transcript variant X4
checkpoint kinase 1, transcript variant X1
checkpoint kinase 1, transcript variant X2
uncharacterized LOC122540526, transcript variant X2
uncharacterized LOC122540526, transcript variant X1
uncharacterized protein LOC122540526 isoform X1
uncharacterized protein LOC122540526 isoform X2
cell adhesion associated, oncogene regulated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell adhesion associated, oncogene regulated, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
cell adhesion molecule-related/down-regulated by oncogenes isoform X4
cell adhesion molecule-related/down-regulated by oncogenes isoform X3
cell adhesion molecule-related/down-regulated by oncogenes isoform X2
cell adhesion molecule-related/down-regulated by oncogenes isoform X1
uncharacterized LOC122540738, transcript variant X1
uncharacterized LOC122540738, transcript variant X2
V-set and immunoglobulin domain-containing protein 10-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
ilvB (bacterial acetolactate synthase)-like, transcript variant X1
ilvB (bacterial acetolactate synthase)-like, transcript variant X2
family with sequence similarity 118 member B, transcript variant X7
family with sequence similarity 118 member B, transcript variant X1
family with sequence similarity 118 member B, transcript variant X8
family with sequence similarity 118 member B, transcript variant X2
family with sequence similarity 118 member B, transcript variant X5
family with sequence similarity 118 member B, transcript variant X3
family with sequence similarity 118 member B, transcript variant X4
family with sequence similarity 118 member B, transcript variant X6
SRP receptor subunit alpha, transcript variant X4
SRP receptor subunit alpha, transcript variant X2
SRP receptor subunit alpha, transcript variant X1
SRP receptor subunit alpha, transcript variant X3
signal recognition particle receptor subunit alpha isoform X4
signal recognition particle receptor subunit alpha isoform X2
signal recognition particle receptor subunit alpha isoform X1
signal recognition particle receptor subunit alpha isoform X3
FAD-dependent oxidoreductase domain containing 1
FAD-dependent oxidoreductase domain-containing protein 1
toll-interleukin 1 receptor (TIR) domain containing adaptor protein, transcript variant X3
toll-interleukin 1 receptor (TIR) domain containing adaptor protein, transcript variant X1
toll-interleukin 1 receptor (TIR) domain containing adaptor protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
toll/interleukin-1 receptor domain-containing adapter protein
uncharacterized LOC122540748, transcript variant X3
uncharacterized LOC122540748, transcript variant X5
uncharacterized LOC122540748, transcript variant X4
uncharacterized LOC122540748, transcript variant X1
uncharacterized LOC122540748, transcript variant X2
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ST3 beta-galactoside alpha-2,3-sialyltransferase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kirre like nephrin family adhesion molecule 3a, transcript variant X2
kirre like nephrin family adhesion molecule 3a, transcript variant X1
kirre like nephrin family adhesion molecule 3a, transcript variant X4
kirre like nephrin family adhesion molecule 3a, transcript variant X3
kirre like nephrin family adhesion molecule 3a, transcript variant X5
kirre like nephrin family adhesion molecule 3a, transcript variant X6
src substrate protein p85-like, transcript variant X1
src substrate protein p85-like, transcript variant X2
src substrate protein p85-like isoform X2
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X7
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X1
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X4
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X5
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X6
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X2
Fli-1 proto-oncogene, ETS transcription factor, transcript variant X3
Friend leukemia integration 1 transcription factor isoform X5
Friend leukemia integration 1 transcription factor isoform X1
Friend leukemia integration 1 transcription factor isoform X2
Friend leukemia integration 1 transcription factor isoform X4
Friend leukemia integration 1 transcription factor isoform X3
v-ets avian erythroblastosis virus E26 oncogene homolog 1, transcript variant X1
v-ets avian erythroblastosis virus E26 oncogene homolog 1, transcript variant X3
v-ets avian erythroblastosis virus E26 oncogene homolog 1, transcript variant X5
v-ets avian erythroblastosis virus E26 oncogene homolog 1, transcript variant X2
v-ets avian erythroblastosis virus E26 oncogene homolog 1, transcript variant X4
ATP-sensitive inward rectifier potassium channel 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
G protein-activated inward rectifier potassium channel 4-like
Rho GTPase activating protein 32b, transcript variant X3
Rho GTPase activating protein 32b, transcript variant X2
Rho GTPase activating protein 32b, transcript variant X6
Rho GTPase activating protein 32b, transcript variant X4
Rho GTPase activating protein 32b, transcript variant X1
Rho GTPase activating protein 32b, transcript variant X5
Rho GTPase activating protein 32b, transcript variant X10
Rho GTPase activating protein 32b, transcript variant X8
Rho GTPase activating protein 32b, transcript variant X7
Rho GTPase activating protein 32b, transcript variant X9
rho GTPase-activating protein 32 isoform X3
rho GTPase-activating protein 32 isoform X1
rho GTPase-activating protein 32 isoform X2
rho GTPase-activating protein 32 isoform X4
rho GTPase-activating protein 32 isoform X5
nuclear factor related to kappaB binding protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear factor related to kappaB binding protein, transcript variant X2
nuclear factor related to kappaB binding protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nuclear factor related to kappaB binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
nuclear factor related to kappa-B-binding protein isoform X2
nuclear factor related to kappa-B-binding protein isoform X3
nuclear factor related to kappa-B-binding protein isoform X4
nuclear factor related to kappa-B-binding protein isoform X1
PR domain containing 10, transcript variant X2
PR domain containing 10, transcript variant X3
PR domain containing 10, transcript variant X1
PR domain containing 10, transcript variant X4
PR domain zinc finger protein 10 isoform X2
PR domain zinc finger protein 10 isoform X3
PR domain zinc finger protein 10 isoform X1
amyloid beta (A4) precursor-like protein 2, transcript variant X1
amyloid beta (A4) precursor-like protein 2, transcript variant X2
amyloid beta (A4) precursor-like protein 2, transcript variant X3
suppressor of tumorigenicity 14 protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
acyl-CoA dehydrogenase family, member 8, transcript variant X1
isobutyryl-CoA dehydrogenase, mitochondrial isoform X1
acyl-CoA dehydrogenase family, member 8, transcript variant X2
isobutyryl-CoA dehydrogenase, mitochondrial isoform X2
sialic acid acetylesterase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sialic acid acetylesterase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sialic acid acetylesterase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
transmembrane protein 107 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transmembrane protein 107 like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
transmembrane protein 107 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
transmembrane protein 107 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
transmembrane protein 107 like isoform X3
transmembrane protein 107 like isoform X2
transmembrane protein 107 like isoform X1
baculoviral IAP repeat-containing protein 5.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: baculoviral IAP repeat-containing protein 5.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
thymocyte expressed, positive selection associated 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
thymocyte expressed, positive selection associated 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
thymocyte expressed, positive selection associated 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transcription factor AP-2 gamma isoform X2
transcription factor AP-2 gamma isoform X1
replication termination factor 2, transcript variant X2
replication termination factor 2, transcript variant X1
replication termination factor 2 isoform X2
replication termination factor 2 isoform X1
glucosaminyl (N-acetyl) transferase family member 7
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7
SPO11 initiator of meiotic double stranded breaks, transcript variant X1
SPO11 initiator of meiotic double stranded breaks, transcript variant X3
SPO11 initiator of meiotic double stranded breaks, transcript variant X2
meiotic recombination protein SPO11 isoform X1
meiotic recombination protein SPO11 isoform X3
meiotic recombination protein SPO11 isoform X2
ribonucleic acid export 1, transcript variant X1
ribonucleic acid export 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
PRELI domain containing 3, transcript variant X1
PRELI domain containing protein 3B isoform X1
PRELI domain containing 3, transcript variant X2
PRELI domain containing protein 3B isoform X2
ATP synthase subunit epsilon, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis, class T
protein spire homolog 1-like, transcript variant X3
protein spire homolog 1-like, transcript variant X1
protein spire homolog 1-like, transcript variant X5
protein spire homolog 1-like, transcript variant X4
protein spire homolog 1-like, transcript variant X6
protein spire homolog 1-like, transcript variant X2
protein spire homolog 1-like, transcript variant X7
protein spire homolog 1-like, transcript variant X9
protein spire homolog 1-like, transcript variant X8
protein spire homolog 1-like, transcript variant X10
protein spire homolog 1-like isoform X10